“What we’re seeing in heart valve disease is a movement away from replacement with mechanical or bioprosthetic valves, as we understand the true morbidity associated with them and now have a strong desire to move toward valve repair and valve-sparing procedures.”
David H. Adams, MD
Marie-Josée and Henry R. Kravis Professor and Chair of the Department of Cardiothoracic Surgery, Program Director for the Mitral Valve Repair Reference Center at The Mount Sinai Hospital
A global leader in the field of heart valve surgery and mitral valve reconstruction, David H. Adams has set national benchmarks with > 99 percent degenerative mitral valve repair rates, while running one of the largest and most respected valve programs in the United States. Last year, patients from more than 35 different states came to New York to be under the care of Dr. Adams and his team. He is the co-inventor of two mitral valve annuloplasty repair rings (the Carpentier-Edwards Physio II Annuloplasty Ring and the Carpentier-McCarthy-Adams IMR ETlogix Ring), and inventor of a new tricuspid annuloplasty ring (Medtronic Tri-Ad Adams Tricuspid Ring), and has royalty agreements with Edwards Lifesciences and Medtronic. He is a co-author with Professor Alain Carpentier of the internationally acclaimed textbook Carpentier’s Reconstructive Valve Surgery, and is a co-director of the annual American College of Cardiology/American Association for Thoracic Surgery Heart Valve Disease Summit, and the Director of the new biennial AATS Mitral Conclave, the largest meeting focused on mitral valve disease held in the world.
Dr. Adams is a highly sought-after speaker both nationally and internationally, and has developed one of the world’s largest video libraries of techniques in valve reconstruction. He is the author of over 200 publications, holds three patents, and is recognized as a leading surgeon scientist and medical expert, having served on the editorial boards of several medical journals, including the Annals of Thoracic Surgery and Cardiology. He is currently the Co-Editor of Seminars in Thoracic and Cardiovascular Surgery. He has also served in an advisory capacity to essentially all industry leaders in cardiovascular surgery. Most recently he was appointed as the Co-Principal Investigator of the upcoming United States FDA pivotal trial of the Medtronic-CoreValve percutaneous aortic valve replacement device.
Dr. Adams’ clinical interests include all aspects of heart valve surgery, with a special emphasis on mitral valve reconstruction. His major research interests include outcomes related to mitral valve repair, novel mitral valve repair strategies, and percutaneous valve replacement. Past research honors include the Alton Ochsner Research Scholarship from the American Association for Thoracic Surgery and the Paul Dudley White Research Fellowship from the American Heart Association. He has also received honorary professorships from Capital University in Beijing and Keio University in Tokyo. In 2009, he received the American Heart Association Award for Achievement in Cardiovascular Science and Medicine.
After receiving his undergraduate and medical education at Duke University, Dr. Adams completed his internship and residency in general and cardiothoracic surgery at Brigham and Women's Hospital and at Harvard Medical School. He followed that with a fellowship in the Cardiothoracic Unit at Harefield Hospital in London under Professor Sir Magdi Yacoub. In addition, he completed a two-year research fellowship under Professor Morris Karnovsky in the Department of Pathology at Harvard Medical School. He later served at Brigham and Women's Hospital as the Associate Chief of Cardiac Surgery and Director of the Brigham Primate Xeno-transplant Laboratory. He has been Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Health System since 2002.